Marktgröße und Marktanteil von Antisense- und RNAi-Therapeutika bis 2025 – 2031
Antisense and RNAi Therapeutics Market Report Analysis
Antisense and RNAi Therapeutics Market
-
CAGR (2025 - 2031)7.50% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alnylam Pharmaceuticals
- Benitec Biopharma Ltd.
- Quark Pharmaceuticals
- Ionis Pharmaceuticals
- Astellas Pharma Inc
- Marina Biosciences
- Sanofi S
- Dicerna Pharmaceuticals
- Tekmira Pharmaceuticals
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Typ
- RNA-Interferenz
- Antisense-RNA
By Verabreichungsweg
- pulmonale Verabreichung
- intravenöse Injektionen
- intradermal
- intraperitoneal
- topisch
- andere
By Anwendung
- Infektionskrankheiten
- Herz-Kreislauf-Erkrankungen
- Krebs
- neurologische Störungen
- Sonstiges
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Get Free Sample For